Loading...
Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan
AIMS/INTRODUCTION: Dipeptidyl peptidase‐4 inhibitors (DPP‐4i) are a common first‐line treatment for type 2 diabetes in Japan. However, little is known about patients’ medication adherence, persistence and discontinuation in this setting. MATERIALS AND METHODS: This was a retrospective cohort study o...
Na minha lista:
| Udgivet i: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5009136/ https://ncbi.nlm.nih.gov/pubmed/27182033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12474 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|